Anti-viral compounds

US9249138B2 · kind B2 · utility

Assignee

• Abb Vie Inc. · US

Inventors

• David A. DeGoey · Salem, US
• Pamela L. Donner · Mundelein, US
• Warren M. Kati · Gurnee, US
• Charles W. Hutchins · Libertyville, US
• Allan C. Krueger · Gurnee, US
• John T. Randolph · Libertyville, US
• Christopher E. Motter · Oak Creek, US
• Preethi Krishnan · Gurnee, US
• Neeta C. Mistry · Mundelein, US
• Tami J. Pilot-Matias · Libertyville, US
• Sachin V. Patel · Round Lake, US
• Xiaoyan Li · Waukegan, US
• Todd N. Soltwedel · Chicago, US
• Lissa T. Nelson · Highland Park, US

Key dates

• Filing date: Sep 4, 2013
• Grant date: Feb 2, 2016
• Expiry date: Sep 4, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D239/48
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.